However, such effects were observed in many patients [8,13,14], who developed substantial increases in ALT and GGT levels during hospitalization Moreover, recent clinical trials using lopinavir and ritonavir in severe COVID-19 patients reported elevated levels of AST, ALT and total bilirubin as adverse side effects in a few patients [47]. This evidence concerns the gene GPT and COVID-19.